 Connection
Dmitri Simberg to Recombinant Fusion Proteins
This is a "connection" page, showing publications Dmitri Simberg has written about Recombinant Fusion Proteins.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.986 |
|
|
|
-
Jacques S, Gaikwad H, Pillatzke J, Moghimi SM, Simberg D. Bioorthogonal tuning of nanosurface opsonisation via click coupling of a complement fusion protein inhibitor. Chem Commun (Camb). 2026 Jul 03; 62(51):12859-12862.
Score: 0.789
-
Li Y, Jacques S, Gaikwad H, Wang G, Banda NK, Holers VM, Scheinman RI, Tomlinson S, Moghimi SM, Simberg D. Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins. Nat Nanotechnol. 2024 02; 19(2):246-254.
Score: 0.163
-
Banda NK, Tomlinson S, Scheinman RI, Ho N, Ramirez JR, Mehta G, Wang G, Vu VP, Simberg D, Kulik L, Holers VM. C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice. Front Immunol. 2020; 11:575154.
Score: 0.033
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|